Gene Query: METRN

Dataset Description Geneva Score
Active translatome profiling with RiboLace in MCF7 cells 137.12
MARS Seq data from human cortical organoids 121.13
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 82.15
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 57.65
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 48.6
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 46.19
Differetially expressed genes after hTR overexpression in U2OS cells 43.46
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 42.16
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 42.03
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 41.5
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 40.44
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 35.48
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 33.5
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 32.94
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 32.88
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 32.28
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 32.28
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 30.88
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 30.25
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 29.97
TCF7L1 knockdown in pancreatic cancer 29.91
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 29.71
Transcriptome of U251 cells overexpression complement component 7 29.34
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 29.19
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 28.04
Transcriptional profiling of microglia; current state of the art and future perspectives 27.46
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 26.41
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 26.41
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 23.51
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 23.51
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 22.69
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 22.69
BAF controls genome accessibility 22.24
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 21.85
Gene Expression Profiling of SPOP Knocked Down Cell 21.64
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 20.62
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 20.51
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 20.35
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 20.35
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 20.09
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 20.05
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 19.33
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 18.72
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 18.61
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 18.56
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 18.19
Genome wide expression change by RNF168 knocking down in MCF-7 cells 18.06
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 17.57
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 17.41
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 17.4
Effect of disulfiram treatment on pediatric high grade glioma 16.94
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 16.62
Differential responses of human fetal brain neural stem cells to Zika virus infection 16.45
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 16.28
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 16.28
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 15.81
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 15.66
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 15.59
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 15.32
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 15.0
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 14.87
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 14.87
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 14.81
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 14.79
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 14.51
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 14.45
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 14.45
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 14.32
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 14.05
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 13.98
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 13.74
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 13.74
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 13.74
Gene expression analysis of the impact of TDP-43 knockout in human cells. 13.66
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 13.26
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 13.16
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 13.15
Paxillin regulates genomic networks in prostate cancer [C4-2] 13.11
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 13.07
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 13.07
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 12.97
Differentiation enhances Zika virus infection in neuronal brain cells 12.93
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 12.84
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 12.79
SUV420H2 knockdown in PANC-1 12.77
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 12.68
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 12.68
LNCaP treated with iBET 12.66
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 12.58
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 12.46
Ebola virus (EBOV) infection of ARPE-19 cells 12.42
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 12.38
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 12.22
TGF-β promotes genomic instability after loss of RUNX3 12.15
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 12.06
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 12.03
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 12.02
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 12.02
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 11.94
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 11.9
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 11.9
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 11.76
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 11.76
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 11.76
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 11.75
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 11.73
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 11.55
DJ-1 is dispensable for human stem cell homeostasis 11.5
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 11.41
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 11.4
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 11.39
ARID1A and ARID1B loss in HCT116 and TOV21G cells 11.35
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 11.32
Mutational landscape of splicing genes and functional consequences across 33 cancer types 11.24
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 11.22
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 11.18
Zika infected neural stem cells 11.13
Transcriptome analysis of Zika infected neural stem cells 11.13
Generating Patterned Kidney Organoids for Studying Development and Diseases 11.09
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 11.02
Lineage specific differentiation is influenced by state of human pluripotency 11.02
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 10.81
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 10.58
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 10.58
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 10.56
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 10.56
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 10.55
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 10.49
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 10.47
Regulation of highly expressed hCINAP on translatome 10.45
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 10.38
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 10.31
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 10.22
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 10.21
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 10.2
R430: A potent inbibitor of DNA and RNA viruses 10.15
Neonatal and adult human testis defined at the single-cell level 10.04
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 9.99
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 9.98
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 9.98
Tumor exosome integrins determine organotropic metastasis 9.98
Genome wide expression change in LCC2 and MCF-7 cells 9.92
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 9.92
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 9.85
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 9.85
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 9.82
Aneuploidy-induced cellular stresses limit autophagic degradation. 9.78
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 9.74
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 9.67
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 9.6
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 9.6
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 9.58
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 9.55
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 9.47
The regulartory role of ZCCHC24 in splicing machinery 9.37
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 9.25
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 9.17
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 9.15
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 9.14
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 9.13
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 9.12
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 9.11
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 9.09
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 9.08
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 9.07
Silencing p300 in MCF7 cells to study expression and alternative splicing 9.05
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 9.05
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 8.99
BASP1 modifies the Tamoxifen response 8.89
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 8.88
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 8.84
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 8.8
Nonpregnant and term pregnant human myometrial tissues 8.8
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 8.79
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 8.79
Aneuploidy triggers an immune response 8.77
Proteomics identifies a marker signature of MAPKi resistance in melanoma 8.72
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 8.7
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 8.53
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.51
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 8.45
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 8.42
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 8.39
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 8.37
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 8.3
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 8.28
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 8.27
Paxillin regulates genomic networks in prostate cancer [PC3] 8.26
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 8.24
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 8.24
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 8.18
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 8.11
The age and genomic integrity of neurons after cortical stroke in humans 8.04
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 8.02
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 8.0
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 8.0
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 7.89
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 7.89
Activity-dependent transcriptional changes in human neurons 7.85
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 7.85
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 7.85
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 7.85
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 7.73
MYCL and EP400 are required for Max and MCPyV mediated gene activation 7.72
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 7.68
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 7.67
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 7.65
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 7.65
U1 snRNP telescripting regulates size-function stratified human genome 7.58
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 7.57
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 7.52
Identification of long noncoding RNAs in T-ALL cell lines 7.51
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 7.49
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 7.47
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 7.45
Transcriptome analysis of U87 cells upon LINC00152 knockdown 7.38
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 7.24
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 7.24
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 7.23
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 7.22
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 7.21
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 7.13
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 7.08
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 7.07
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 7.01
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 7.01
High-throughput sequencing of PROMPT-enriched samples. 6.97
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 6.97
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 6.94
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 6.9
NHLRC1 re-expression in cancer cells 6.84
The transcriptome effect of overexpressing EZH2 in MCF7 6.83
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 6.77
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 6.76
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 6.72
CHD1 regulates cell fate determination by activation of differentiation-induced genes 6.71
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 6.71
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 6.7
RNA splicing alteration on glioblastoma and normal neural stem cells 6.7
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 6.67
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 6.66
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 6.62
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 6.62
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 6.61
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 6.61
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 6.59
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 6.56
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 6.55
Lipid degradation promotes prostate cancer cell survival 6.53
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 6.47
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 6.47
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 6.45
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 6.45
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 6.43
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 6.43
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 6.31
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 6.31
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 6.21
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 6.19
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 6.1
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 6.03
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 6.0
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 5.98
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 5.9
Induced DNA demethylation, genome instability and transcription 5.9
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 5.9
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 5.84
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 5.83
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 5.73
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 5.73
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 5.73
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 5.72
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 5.7
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 5.58
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 5.5
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 5.46
RNA-sequencing in immortalized human mammary epithelial cells 5.46
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 5.41
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 5.41
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 5.23
RNA-seq of young and quiescent MRC-5 human fibroblasts 5.16
Patient-derived xenograft platform for metastatic melanoma 5.16
AUF-1 affected genes in human skin cells 5.12
Identification of transcription start sites for human A549 cell line using ReCappable-seq 5.11
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 5.1
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 5.02
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.94
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 4.93
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 4.93
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 4.9
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 4.85
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 4.85
Regionally specified human pluripotent stem cell-derived astrocytes 4.83
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 4.81
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 4.8
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 4.71
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 4.66
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 4.65
Molecular analysis of renal cell carcinoma with unclassfied histology 4.65
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.61
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.6
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 4.6
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 4.58
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 4.51
Energy Metabolism during Anchorage-Independence 4.49
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 4.47
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 4.47
JAK dependent survival of ALK- ALCL 4.45
Investigate A2M treatment on human prostate cancer and mouse liver 4.45
Investigate A2M treatment on human prostate cancer xenograft in mice 4.45
CUREfast: Accelerating research with families 4.42
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 4.37
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 4.36
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 4.35
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 4.31
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 4.27
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 4.26
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 4.24
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 4.2
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 4.18
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 4.18
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 4.15
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 4.13
Genome-wide identification of cancer-specific alternative splicing in circRNA 4.09
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 4.01
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 3.97
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.97
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.97
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 3.91
Functional astrocytes differentiated from hiPSCs 3.9
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 3.89
Total RNA sequencing of APC mutant and wt colonic organoids 3.86
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 3.81
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 3.78
STX4 Over-Expression in Human islets 3.73
Genome-wide discovery of human splicing branchpoints 3.72
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 3.66
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 3.65
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 3.65
Gene expression profiling of papillary thyroid cancer from central and invasive regions 3.62
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 3.52
RNAseq of cell lines with knocked in ESR1 mutations 3.52
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 3.51
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 3.48
Transcriptome analyses of human pancreatic islets and pseudoislets 3.47
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 3.47
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 3.46
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 3.45
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 3.44
Global expression profiles in cardiac progenitor cells generated by ISX-9 3.44
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 3.38
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 3.38
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 3.33
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 3.33
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.33
Genome-wide discovery of human splicing branchpoints [RNAse] 3.32
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 3.31
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.29
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 3.18
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 3.17
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 3.1
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 3.02
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 3.02
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 3.01
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 3.0
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 2.99
FOXP2's impact on the primate transcriptome 2.96
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 2.87
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 2.86
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.77
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 2.76
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 2.76
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 2.75
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 2.71
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.69
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 2.68
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.65
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.61
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.6
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 2.59
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.59
N6-methyladenine DNA Modification in Glioblastoma 2.59
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 2.55
RNA-seq of tumor cells following angiopellosis extravasation 2.46
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 2.46
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 2.44
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 2.36
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.36
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 2.36
RNA-seq analysis of gene expression patterns during hESC neural differentiation 2.33
hESC neural differentiation 2.33
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 2.31
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 2.27
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 2.27
Dissecting neural differentiation regulatory networks through epigenetic footprinting 2.25
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 2.24
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.23
Single cell transcriptome of peritoneal cells 2.21
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 2.19
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 2.19
RNA editing in nascent RNA affects pre-mRNA splicing 2.19
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 2.17
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.13
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.12
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 2.1
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 2.08
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 2.08
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 2.07
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 2.03
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 1.96
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 1.95
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 1.95
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 1.93
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 1.93
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.9
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.88
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.83
A single cell reference map for human blood and tissue T cell activation 1.8
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 1.8
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 1.78
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 1.77
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.72
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 1.69
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.69
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.69
Interaction between mitoNEET and NAF-1 in cancer cells 1.68
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 1.63
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.62
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 1.61
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 1.61
Effect of ILF3 on translation during homeostasis and the antiviral response 1.6
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.56
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 1.55
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 1.54
Subtle asymmetry of gene expression in embryonic and foetal human brains 1.53
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.53
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 1.51
Role of FGFR1 in neuronal devlopment 1.49
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 1.47
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.43
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 1.35
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.32
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.32
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 1.29
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 1.29
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.25
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.23
Effects of transcription on genome - nuclear lamina interactions 1.23
FGF2 regulation of gene expression in stable inducible Neurons 1.22
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 1.13
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.12
The DNA methylation landscape of human melanoma [RNA-Seq] 1.1
The DNA methylation landscape of human melanoma 1.1
SF3B1 Degron knockdown RNA-seq 1.07
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.99
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 0.99
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 0.96
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 0.95
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.95
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.92
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.87
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.85
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.76
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.74
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.71
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.71
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.66
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.66
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 0.66
KLF6-dependent transcription in renal cancer cells 0.64
BMS-470539 on human synovial fibroblasts 0.62
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.62
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.58
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.57
Expression profiling of converted and control dermal BJ fibroblasts 0.57
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.5
iPSC derived motor neuron cultures from C9ORF72 carriers 0.48
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.46
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.46
Fusion discovery in breast cancer cell line 0.42
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.42
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.38
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.33
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.32
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.3
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.29
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.29
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.25
Global epigenomic reconfiguration during mammalian brain development 0.21
Gene expression analysis of breast cancer cell-lines 0.2
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.2
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.19
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.18
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 0.1
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.06
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.03
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.03
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.01
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.01
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation